Dusko Nezic

Dusko Nezic

Auto-generated profile, based on publicly available information

Dusko Nezic

Department of Cardiac Surgery, "Dedinje" Cardiovascular Institute, M. Tepica 1, 11000 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2015 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
IPIvana Petrovic
Ivana Petrovic
DNDusko Nezic
Dusko Nezic
MPMiodrag Peric
Miodrag Peric
PMPredrag Milojevic
Predrag Milojevic
ODOlivera Djokic
Olivera Djokic
Petar OtaševićPetar Otašević
Petar Otašević
There is ongoing debate regarding the efficacy of the radial artery (RA) as an aortocoronary conduit, with few solid data regarding long-term clinical results. We sought to determine if the use of the RA as the second arterial conduit, beside left internal thoracic artery (LITA), would improve long-term clinical outcome after CABG as compared to saphenous vein graft (SVG). Between March 2001 and November 2003, 200 patients underwent isolated CABG and were randomized in 1:1 fashion to receive either LITA and RA grafts or LITA and SVGs. The primary end point was composite of cardiovascular mortality, non-fatal myocardial infarction and need for repeat myocardial revascularization (either surgical or percutaneous). There was no significant difference in absolute survival, with 12 deaths in each group during the study period (log rank = 0.01, p = 0.979). There were 3 and 2 cardiac deaths in RA and SVG groups, respectively. There was no difference in long-term clinical outcome between the groups (log rank = 0.450, p = 0.509). Eleven patients in RA group had one or more non-fatal events; 7 patients suffered a myocardial infarction, 9 patients underwent percutaneous coronary angioplasty, and 1 patient required redo coronary surgery. Likewise, 13 patients in SVG group had non-fatal event; 7 patients had myocardial infarction, 13 patients had percutaneous coronary intervention and 3 patients required redo coronary surgery. Angiograms were performed in 23 patients in RA group (patency rate 92 %) and 24 in SVG group (patency rate 86 %) (p = 0.67). In this small randomised study our data indicate that there is no difference in the 8 year clinical outcomes in relatively young patients between those having a RA or a saphenous vein graft used as a second conduit, beside LITA, for surgical myocardial revascularisation.

16 December 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
DNDuško G Nežić
Duško G Nežić
IŽIgor S Živković
Igor S Živković
MMMiroslav Milicic
Miroslav Milicic
PMPetar A Milačić
Petar A Milačić
DKDragana N Košević
Dragana N Košević
SMSlobodan V Mićović
Slobodan V Mićović
The German Registry of Acute Aortic Dissection Type A (GERAADA) on-line score calculator to predict 30-day mortality in patients undergoing surgery for acute type A aortic dissection (ATAAD) was recently launched. Using the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), it is also possible to predict operative mortality for the same type of surgery. The goal of our study was to validate the prediction accuracy of these 2 on-line risk prediction models. Prospectively collected data for EuroSCORE II risk factors as well as all data for GERAADA scoring were extracted from an institutional database for 147 patients who underwent surgery for ATAAD between April 2018 and April 2021. The discriminative power was assessed using area under the receiver operating characteristic curve. The calibration of the models was tested by the Hosmer–Lemeshow statistics and by using the observed-to-expected (O/E) mortality ratio with the 95% confidence interval. The observed operative mortality was 14.3%. The mean predicted mortality rates for the GERAADA score and the EuroSCORE II were 15.6% and 10.6%, respectively. The EuroSCORE II discriminative power (area under the curve = 0.799) significantly outperformed the discriminatory power of the GERAADA score (area under the curve = 0.550). The Hosmer–Lemeshow statistics confirmed good calibration for both models (P-values of 0.49 and 0.29 for the GERAADA score and the EuroSCORE II, respectively). The O/E mortality ratio certified good calibration for both scores [GERAADA score (O/E ratio of 0.93, 95% confidence interval: 0.53–1.33); EuroSCORE II (O/E ratio of 1.35, 95% confidence interval: 0.77–1.93)]. The EuroSCORE II has better discriminative power for predicting operative mortality in ATAAD surgery than the GERAADA score. Both scores confirmed good calibration ability.

22 June 2012 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
DNDusko Nezic
Dusko Nezic
MBMilorad Borzanovic
Milorad Borzanovic
TSTatjana Spasic
Tatjana Spasic
PVPetar Vukovic
Petar Vukovic
We read with great interest the article by Nashef et al. [1] regarding the construction and validation of the EuroSCORE II risk model. This manuscript is an outstanding contribution in the creation of a risk stratification model that is robust enough for use in cardiac surgery worldwide.

1 April 2016 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
DNDusko Nezic
Dusko Nezic
TSTatjana Spasic
Tatjana Spasic
Slobodan MicovicSlobodan Micovic
Slobodan Micovic
DKDragana Kosevic
Dragana Kosevic
IPIvana Petrovic
Ivana Petrovic
MBMilorad Borzanovic
Milorad Borzanovic

13 April 2011 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
SCSuad Catovic
Suad Catovic
ZPZoran B Popovic
Zoran B Popovic
NTNebojša M. Tasić
Nebojša M. Tasić
DNDusko Nezic
Dusko Nezic
PMPredrag Milojevic
Predrag Milojevic
Petar OtaševićPetar Otašević
Petar Otašević
Background: Prognostic value of concomitant aprtic regurgitation (AR) in patients operated for severe aortic stenosis (AS) is not clarified. The aim of this study was to prospectively examine the impact of presence and severity of concomitant AR in patients operated for severe AS on long-term functional capacity, left ventricular (LV) function and mortality. Methods: Study group consisted of 110 consecutive patients operated due to severe AS. The patients were divided into AS group (56 patients with AS without AR or with mild AR) and AS+AR group (54 patients with AS and moderate, severe or very severe AR). Follow-up included clinical examination, six minutes walk test (6MWT) and echocardiography 12 and 104 months after AVR. Results: Patients in AS group had lower LV volume indices throughout the study than patients in AS+AR group. Patients in AS group did not have postoperative decrease in LV volume indices, whereas patients in AS+AR group experienced decrease in LV volume indices at 12 and 104 months. Unlike LV volume indices, LV mass index was significantly lower in both groups after 12 and 104 months as compared to preoperative values. Mean LVEF remained unchanged in both groups throughout the study. NYHA class was improved in both groups at 12 months, but at 104 months remained improved only in patients with AS. On the other hand, distance covered during 6MWT was longer at 104 months as compared to 12 months only in AS+AR group (p = 0,013), but patients in AS group walked longer at 12 months than patients in AS+AR group (p = 0,002). There were 30 deaths during study period, of which 13 (10 due to cardiovascular causes) in AS group and 17 (12 due to cardiovascular causes) in AS+AR group. Kaplan-Meier analysis showed that the survival probability was similar between the groups. Multivariate analysis identified diabetes mellitus (beta 1.78, p = 0.038) and LVEF < 45% (beta 1.92, p = 0.049) as the only independent predictor of long-term mortality. Conclusion: Our data indicate that the preoperative presence and severity of concomitant AR has no influence on long-term postoperative outcome, LV function and functional capacity in patients undergoing AVR for severe AS.

4 January 2012 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
DNDusko Nezic
Dusko Nezic
AKAleksandar Knezevic
Aleksandar Knezevic
SBSasa Borovic
Sasa Borovic
MJMiomir Jovic
Miomir Jovic
Mitral valve replacement (MVR) in the presence of the extensive calcification of the mitral annulus is a technical challenge. The heavily calcified annulus can cause great difficulty in the insertion of a prosthetic valve and periprosthetic leakage later on. Vigorous annular decalcification may cause circumflex coronary artery injury, atrioventricular rupture and thromboembolic events. We herein describe a surgical technique for MVR in such cases while focusing on partial decalcification of the posterior mitral annulus and its reinforcement and buttressing with the transferred anterior mitral leaflet (AML). At the same time, the transferred AML supports the posterior annular region and maintains ventricular–annular continuity, thus preserving the left ventricular function.